Agree Sam, 1102 has very quickly gone from an experimental drug for MS to now, potentially, a block buster solution for inflammation across a wide range of indications, competing head on with Corticosteroids in a 100B+ market. Negotiating the complexities of a deal this size will require an industry champion with unique skill sets and extensive experience in exchange of high value assets, partnership deals and take overs. We are entering into the big league now, we need a strong assertive deal maker on the board to get this over the line.
- Forums
- ASX - By Stock
- PER
- Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA
Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA, page-30
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
-0.003(3.80%) |
Mkt cap ! $68.51M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.5¢ | $47.57K | 622.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1598 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 140942 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1598 | 0.076 |
1 | 100000 | 0.075 |
1 | 69866 | 0.074 |
2 | 111973 | 0.073 |
1 | 55400 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 140942 | 2 |
0.080 | 243231 | 2 |
0.081 | 198015 | 2 |
0.082 | 75174 | 2 |
0.083 | 93000 | 1 |
Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |